PDS Biotechnology Correlations
PDSB Stock | USD 1.26 0.01 0.79% |
The current 90-days correlation between PDS Biotechnology Corp and Inozyme Pharma is -0.02 (i.e., Good diversification). The correlation of PDS Biotechnology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
PDS Biotechnology Correlation With Market
Modest diversification
The correlation between PDS Biotechnology Corp and DJI is 0.24 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding PDS Biotechnology Corp and DJI in the same portfolio, assuming nothing else is changed.
PDS |
Moving together with PDS Stock
0.62 | ILMN | Illumina | PairCorr |
0.72 | INZY | Inozyme Pharma | PairCorr |
0.74 | KURA | Kura Oncology | PairCorr |
0.94 | ABOS | Acumen Pharmaceuticals | PairCorr |
0.94 | ADTX | Aditxt Inc | PairCorr |
0.66 | ANAB | AnaptysBio | PairCorr |
0.9 | STRO | Sutro Biopharma | PairCorr |
0.92 | TCRX | Tscan Therapeutics | PairCorr |
0.81 | TERN | Terns Pharmaceuticals | PairCorr |
0.9 | CRNX | Crinetics Pharmaceuticals Earnings Call Today | PairCorr |
0.71 | CTMX | CytomX Therapeutics | PairCorr |
0.86 | DAWN | Day One Biopharmaceu | PairCorr |
0.65 | TLKMF | Telkom Indonesia Tbk | PairCorr |
Moving against PDS Stock
0.76 | PHGE | Biomx Inc | PairCorr |
0.68 | GANX | Gain Therapeutics | PairCorr |
0.64 | OPT | Opthea | PairCorr |
0.64 | PFE | Pfizer Inc Aggressive Push | PairCorr |
0.57 | LTRN | Lantern Pharma | PairCorr |
0.56 | CUE | Cue Biopharma | PairCorr |
0.48 | FENC | Fennec Pharmaceuticals | PairCorr |
0.34 | A | Agilent Technologies Earnings Call Today | PairCorr |
0.69 | CGTX | Cognition Therapeutics | PairCorr |
0.65 | DBVT | DBV Technologies Earnings Call This Week | PairCorr |
0.35 | CPRX | Catalyst Pharmaceuticals Earnings Call Today | PairCorr |
0.85 | SSNLF | Samsung Electronics | PairCorr |
0.79 | OBI | Ondine Biomedical | PairCorr |
0.63 | GPI | Group 1 Automotive | PairCorr |
0.61 | EC | Ecopetrol SA ADR Earnings Call Today | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between PDS Stock performing well and PDS Biotechnology Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze PDS Biotechnology's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
MREO | 2.78 | (0.36) | 0.00 | (0.38) | 0.00 | 6.16 | 20.77 | |||
TERN | 3.21 | (0.67) | 0.00 | 0.53 | 0.00 | 5.17 | 26.61 | |||
INZY | 4.08 | (1.20) | 0.00 | 0.79 | 0.00 | 7.72 | 38.13 | |||
HOOK | 3.60 | (0.68) | 0.00 | 2.63 | 0.00 | 6.90 | 32.80 | |||
EFTR | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
ENVB | 4.63 | (1.87) | 0.00 | 14.70 | 0.00 | 9.78 | 65.81 | |||
OCEA | 6.74 | (2.27) | 0.00 | (4.76) | 0.00 | 15.38 | 51.00 | |||
AVRO | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PDS Biotechnology Corporate Management
Joe Dervan | VP Development | Profile | |
Lars MBA | Chief Officer | Profile | |
Deanne Randolph | Head Relations | Profile | |
Gregory Conn | Chief Scientific Officer | Profile | |
Spencer JD | Senior Counsel | Profile | |
Nathalie Riebel | VP Operations | Profile | |
Janetta Trochimiuk | Controller | Profile |